Clinical Trial Update: Exploratory Study of DHA in Systemic Lupus Erythematosus Patients [Phase 2]

View source ↗

Summary

A Phase 2 exploratory study evaluating docosahexaenoic acid (DHA) in patients with systemic lupus erythematosus is being conducted, with status currently unknow…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• DHA (Docosahexaenoic acid)

Snippet

Sponsor: Kunming Pharmaceuticals, Inc. | Conditions: Systemic Lupus Erythematosus | Phase 2 | Status: UNKNOWN